News Daily News Embolic Protection Use During TAVI Declined After PROTECTED TAVR Todd Neale March 21, 2025
News Daily News Aortic Wall Thrombus in TAVI Patients Portends Thromboembolic Events Caitlin E. Cox July 23, 2024
News Daily News FDA: No Signs of Link Between GLP-1s and Suicidal Thoughts, Actions Todd Neale January 12, 2024
News Daily News Angioedema Risk No Higher With ARNI Than With ACE Inhibitors, ARBs Todd Neale January 23, 2023
News Daily News Higher Annual TAVI Volumes Linked to Greater Use of Embolic Protection L.A. McKeown August 23, 2022
News Daily News Embolic Protection Snags Debris in Nearly All Lower-Risk TAVI Patients Todd Neale March 16, 2022
News Daily News FDA Data Raise Red Flags for Suture-Based Vascular Closure Devices Caitlin E. Cox February 11, 2021
News Daily News Cerebral Embolic Protection Use Low During TAVI, Not Tied to Stroke Risk Todd Neale January 20, 2021
News Daily News FDA Approves Lotus Edge, Ushering Third Device Into US Market Shelley Wood April 24, 2019
News Daily News SURTAVI Stroke Analysis Published, Confirms Less Early Stroke With TAVR Todd Neale October 22, 2018
News Daily News Add-on Payment Now in Effect for Sentinel Protection Device During TAVR Todd Neale October 01, 2018
News Daily News Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific Shelley Wood July 20, 2018
News Daily News Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis Caitlin E. Cox February 05, 2018
News Daily News FDA Clears Sentinel Cerebral Protection Device for Use During TAVR Shelley Wood June 05, 2017
News Daily News FDA Advisors Positive on Sentinel Cerebral Protection Device in TAVR Shelley Wood February 23, 2017